Position in EBS
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$1,275,594
-$246,982 QoQ
Shares Held
152,219
-17.0% QoQ
Ownership
0.297%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#44
of 194 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in EBS Over Time
Shares Held
Position Value (USD)
Derivatives in EBS
reported options exposure · as of Jun 30, 2021CallValue
$592,106
CallShares
9,400
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026BANK OF AMERICA CORP /DE/ holds $1,596,028,663 across 49 Drug Manufacturers - Specialty & Generic names. EBS ranks #39 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
3,924,926 | $282,045,178 | |
| 2 | LQDA |
Liquidia Corp
|
1,991,566 | $158,787,554 | |
| 3 | TEVA |
Teva Pharmaceutical Industries Ltd
|
4,227,607 | $143,231,322 | |
| 4 | VTRS |
Viatris Inc
|
7,356,708 | $116,824,520 | |
| 5 | NBIX |
Neurocrine Biosciences Inc
|
619,352 | $104,385,582 | |
| 6 | HLN |
Haleon plc
|
10,850,097 | $101,231,403 | |
| 7 | UTHR |
UNITED THERAPEUTICS Corp
|
179,235 | $97,114,896 | |
| 8 | ELAN |
Elanco Animal Health Inc
|
3,909,871 | $96,221,922 |
All Filings in EBS
Export CSV
27 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,275,594 | 152,219 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $1,522,576 | 183,443 | Shares | Defined | 2026-05-18 | |
| 2025-12-31 | $1,816,225 | 146,944 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $789,405 | 89,502 | Shares | Defined | 2026-02-03 | |
| 2025-06-30 | $1,977,460 | 309,947 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $453,518 | 93,317 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $3,174,865 | 332,099 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $2,655,674 | 318,045 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $3,784,724 | 554,945 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $1,007,098 | 398,063 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $1,016,595 | 423,582 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $1,100,079 | 323,553 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $3,195,520 | 434,765 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $6,191,973 | 597,681 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $3,458,332 | 292,831 | Shares | Defined | 2023-02-10 | |
| 2022-09-30 | $3,228,364 | 153,805 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $6,573,959 | 211,790 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $17,016,041 | 414,419 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $20,281,664 | 466,567 | Shares | Defined | 2022-02-08 | |
| 2021-09-30 | $29,970,147 | 598,565 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $15,699,497 | 249,238 | Shares | Defined | 2021-09-13 | |
| 2021-06-30 | $592,106 | 9,400 | Call | Defined | 2021-09-13 | |
| 2021-03-31 | $30,765,098 | 331,128 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $23,320,278 | 260,271 | Shares | Defined | 2021-02-10 | |
| 2020-09-30 | $25,310,473 | 244,948 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $25,463,520 | 321,997 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $16,634,804 | 287,501 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||